Alexander Cheung

956 total citations
22 papers, 303 citations indexed

About

Alexander Cheung is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Cheung has authored 22 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Cheung's work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (4 papers) and Immune cells in cancer (4 papers). Alexander Cheung is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (4 papers) and Immune cells in cancer (4 papers). Alexander Cheung collaborates with scholars based in United States, Sweden and United Kingdom. Alexander Cheung's co-authors include Jennifer Bacik, David R. Spriggs, Luis H. Camacho, D.R. Springall, S.R. Bloom, N.D. Christofides, J.M. Polak, F E Bauer, Alain Cadieux and Lawrence Fong and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Alexander Cheung

22 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Cheung United States 9 97 77 63 62 50 22 303
Susan E. Lacy United States 10 152 1.6× 252 3.3× 29 0.5× 52 0.8× 19 0.4× 14 465
Benjamin Levinson United States 11 125 1.3× 133 1.7× 15 0.2× 27 0.4× 44 0.9× 26 344
E. Murphy Ireland 10 60 0.6× 87 1.1× 70 1.1× 103 1.7× 39 0.8× 17 434
Robert Doiron United States 5 73 0.8× 167 2.2× 21 0.3× 55 0.9× 21 0.4× 6 376
Léna Absi France 13 39 0.4× 60 0.8× 94 1.5× 116 1.9× 32 0.6× 25 625
Panagiotis Ntellas Greece 12 107 1.1× 104 1.4× 29 0.5× 40 0.6× 29 0.6× 37 373
Elisabetta Ghiglione Italy 6 218 2.2× 38 0.5× 44 0.7× 29 0.5× 23 0.5× 9 403
I Bonaventura Spain 8 27 0.3× 76 1.0× 82 1.3× 28 0.5× 27 0.5× 11 411
Yoshimi Nakamura Japan 10 47 0.5× 78 1.0× 13 0.2× 38 0.6× 33 0.7× 39 364
Veronika Weyer‐Elberich Germany 10 80 0.8× 34 0.4× 15 0.2× 75 1.2× 23 0.5× 32 273

Countries citing papers authored by Alexander Cheung

Since Specialization
Citations

This map shows the geographic impact of Alexander Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Cheung more than expected).

Fields of papers citing papers by Alexander Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Cheung. The network helps show where Alexander Cheung may publish in the future.

Co-authorship network of co-authors of Alexander Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Cheung. A scholar is included among the top collaborators of Alexander Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Cheung. Alexander Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Rahul, Jacqueline Vuky, David James VanderWeele, et al.. (2025). Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 43(15). 1824–1834. 5 indexed citations
2.
Ledergor, Guy, Kaichun Wu, Elizabeth McCarthy, et al.. (2024). CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy. Blood Advances. 8(13). 3562–3575. 19 indexed citations
3.
Filbert, Erin L., Brandon K. Chen, Alexander Cheung, et al.. (2024). Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. Cancer Research Communications. 4(1). 200–212. 6 indexed citations
4.
Chen, Brandon K., Michael L. Cheng, Eric Liu, et al.. (2024). Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer. Cancer Immunology Research. 12(4). 453–461. 3 indexed citations
5.
Huppert, Laura A., Amelia S. Gliwa, Alexander Cheung, et al.. (2023). Phase Ib study of talimogene laherparepvec (T-VEC) in combination with chemotherapy (CT) or endocrine therapy (ET) in patients with metastatic, unresectable, or locoregionally recurrent HER2-negative breast cancer (BC).. Journal of Clinical Oncology. 41(16_suppl). 1091–1091. 2 indexed citations
6.
Keenan, Bridget P., Elizabeth McCarthy, Arielle Ilano, et al.. (2022). Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis. Cell Reports. 40(12). 111384–111384. 22 indexed citations
7.
Zhang, Li, Jason Cham, Tao He, et al.. (2021). Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy. Journal of Immunological Methods. 494. 113041–113041. 11 indexed citations
8.
Choudhury, Atish D., Lucia Kwak, Alexander Cheung, et al.. (2021). Randomized phase II study evaluating the addition of pembrolizumab to radium-223 in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 98–98. 12 indexed citations
9.
Zhang, Li, Meenal Sinha, Sumit K. Subudhi, et al.. (2021). The impact of prior radiation therapy on outcome in a phase 2 trial combining sipuleucel-T (SipT) and ipilimumab (Ipi) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 39(15_suppl). 5045–5045. 3 indexed citations
10.
Sinha, Meenal, Li Zhang, Sumit K. Subudhi, et al.. (2021). Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer. Journal for ImmunoTherapy of Cancer. 9(5). e002254–e002254. 34 indexed citations
11.
Keenan, Bridget P., Elizabeth McCarthy, Arielle Ilano, et al.. (2021). Circulating Monocytes Associated with Anti-PD-1 Resistance in Human Biliary Cancer Induce T Cell Paralysis. SSRN Electronic Journal. 1 indexed citations
12.
Buelow, Ben, Kevin Dang, Pranjali Dalvi, et al.. (2020). Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e17583–e17583. 1 indexed citations
13.
Sinha, Meenal, Courtney B. Betts, Gina Choe, et al.. (2019). Immune modulatory effects of ibrutinib in pancreatic ductal adenocarcinoma. Annals of Oncology. 30. iv40–iv40. 2 indexed citations
14.
Ledergor, Guy, Elizabeth McCarthy, Nina Shah, et al.. (2019). Single cell Dissection of Resistance to anti-BCMA CAR-T cell Therapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e25–e26. 1 indexed citations
15.
Kelley, Robin Kate, Spencer C. Behr, Jimmy J. Hwang, et al.. (2018). Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).. Journal of Clinical Oncology. 36(4_suppl). 386–386. 13 indexed citations
16.
Li, Lin, Mark Fisher, Wei Ling Lau, et al.. (2014). Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literature. Hemodialysis International. 19(3). E1–7. 7 indexed citations
17.
Camacho, Luis H., Jennifer Bacik, Alexander Cheung, & David R. Spriggs. (2005). Presentation and subsequent publication rates of phase I oncology clinical trials. Cancer. 104(7). 1497–1504. 42 indexed citations
18.
Cheung, Alexander, et al.. (2001). Reliability of nurses' neurological assessments in the cardiothoracic surgical intensive care unit. American Journal of Critical Care. 10(5). 298–305. 6 indexed citations
19.
Wun, Ted, et al.. (1999). Platelet-Erythrocyte Adhesion in Sickle Cell Disease. Journal of Investigative Medicine. 47(3). 121–127. 47 indexed citations
20.
Cheung, Alexander, J.M. Polak, F E Bauer, et al.. (1985). Distribution of galanin immunoreactivity in the respiratory tract of pig, guinea pig, rat, and dog.. Thorax. 40(12). 889–896. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan E. Lacy Breakdown of academic impact, for papers by Benjamin Levinson Breakdown of academic impact, for papers by E. Murphy Breakdown of academic impact, for papers by Robert Doiron Breakdown of academic impact, for papers by Léna Absi Breakdown of academic impact, for papers by Panagiotis Ntellas Breakdown of academic impact, for papers by Elisabetta Ghiglione Breakdown of academic impact, for papers by I Bonaventura Breakdown of academic impact, for papers by Yoshimi Nakamura Breakdown of academic impact, for papers by Veronika Weyer‐Elberich
Rankless by CCL
2026